These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15050497)

  • 1. Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction.
    Vetrano A; Carotenuto R; Corsini F; Schioppa M; Martone A; Melorio S; Sideri F; Romano S; Chieffo C; Corsini G
    Am J Cardiol; 2004 Apr; 93(7):914-6. PubMed ID: 15050497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.
    van 't Hof AW; Ernst N; de Boer MJ; de Winter R; Boersma E; Bunt T; Petronio S; Marcel Gosselink AT; Jap W; Hollak F; Hoorntje JC; Suryapranata H; Dambrink JH; Zijlstra F;
    Eur Heart J; 2004 May; 25(10):837-46. PubMed ID: 15140531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of tirofiban therapy in very old patients with acute coronary syndrome or non-Q-wave myocardial infarction.
    Graf C; Nkoulou R; Trombert V; Perrenoud JJ
    J Am Geriatr Soc; 2005 Jan; 53(1):172-3. PubMed ID: 15667404
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion.
    Straub S; Junghans U; Jovanovic V; Wittsack HJ; Seitz RJ; Siebler M
    Stroke; 2004 Mar; 35(3):705-9. PubMed ID: 14752128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase.
    Meyners W; Peters S; Trümmel M; Koehler B
    Z Kardiol; 2004 May; 93(5):407-12. PubMed ID: 15160277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS).
    Morrow DA; Sabatine MS; Antman EM; Cannon CP; Braunwald E; Theroux P
    Am J Cardiol; 2004 Sep; 94(6):774-6. PubMed ID: 15374786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction.
    Ronner E; van Domburg RT; van den Brand MJ; de Feyter PJ; Foley DP; van der Giessen WJ; Serruys PW; Simoons ML
    Eur Heart J; 2002 Oct; 23(19):1529-37. PubMed ID: 12242073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tirofiban-induced coronary thrombolysis.
    Jayasundera TG; Feldman DN; Marmur JD
    J Invasive Cardiol; 1999 Mar; 11(3):138-40. PubMed ID: 10745501
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
    Chawla AK; Nambiar CA; Murad AA
    Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy: new dimensions 2009.
    Guha S; Mukherjee S; Hema MB
    Indian Heart J; 2009; 61(5):415-21. PubMed ID: 20635755
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of thrombolysis in acute myocardial infarction.
    Gambhir DS
    Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pilot study of the effectiveness of combination therapy with reduced dose alteplase and the glycoprotein IIb/IIIa antagonist tirofiban in acute myocardial infarct].
    Peters S; Trümmel M; Brattström A; Meyners W
    Z Kardiol; 2002 Mar; 91(3):233-7. PubMed ID: 12001538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
    Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
    Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
    Patel VB; Moliterno DJ
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.